Back to Clinical Trials Overview

Back To Cancer Clinical Trials

Your search for "Genitourinary" returned 15 results:


A Study of MRI/US Fusion Imaging and Biopsy in Combination with Nanoparticle Directed Focal Therapy in Prostate Cancer
Principal Investigator(s): Dr. Ardeshir Rastinehad

Metformin - Rising PSA Remote Trial (M-RePoRT)
Principal Investigator(s): Dr. Matthew Galsky

A Randomized, Double Blind, Multicenter, Parallel-group, Phase III Study to Evaluate Efficacy and Safety of DCVAC/PCa Versus Placebo in Men with Metastatic Castration Resistant Prostate Cancer Eligible for 1st Line Chemotherapy
Principal Investigator(s): Dr. William Oh

A Phase II, Multicenter, Single-Arm Study of MPDL3280A in Patients with Locally Advanced or Metastatic Urothelial Bladder Cancer
Principal Investigator(s): Matthew Galsky

A Phase I/II Study of Varlilumab (CDX-1127) in Combination with Sunitinib in Patients with Metastatic Clear Cell Renal Cell Carcinoma
Principal Investigator(s): Dr. Che-Kai Tsao

Metformin - Rising PSA Remote Trial (M-RePoRT)
Principal Investigator(s): Dr. Matthew Galsky

A Phase III Randomized Clinical Trial of Pembrolizumab (MK-3475) versus Paclitaxel,
Principal Investigator(s): Dr. Matthew Galsky

A Phase I, open-label, multicenter, dose escalation study of oral BGJ398, a pan FGFR kinase inhibitor, in adult patients with advanced solid malignancies
Principal Investigator(s): Dr. Matthew Galsky

A phase II single arm clinical trial of nivolumab (BMS-936558) in subjects with metastatic or unresectable urothelial cancer who have progressed or recurred following treatment with a platinum agent
Principal Investigator(s): Dr. Matthew Galsky

Phase II Trial of Everolimus or Everolimus plus Paclitaxel as First-line Therapy in Cisplatin-ineligible Patients with Advanced Urothelial Carcinoma
Principal Investigator(s): Matthew Galsky

PHASE I STUDY OF IN SITU AUTOLOGOUS VACCINATION AGAINST PROSTATECANCER WITH INTRATUMORAL AND SYSTEMIC HILTONOL® (POLY-ICLC) PRIOR TORADICAL PROSTATECTOMY
Principal Investigator(s): Dr. Ash Tewari

A Randomized, Double-Blinded, Phase II Study of Maintenance Pembrolizumab versus Placebo after First-line Chemotherapy in Patients with Metastatic Urothelial Cancer
Principal Investigator(s): Dr. Matthew Galsky

Phase II Trial of Gemcitabine, Cisplatin, plus Ipilimumab as First-line Treatment for Patients with Metastatic Urothelial Carcinoma
Principal Investigator(s): Matthew Galsky

An International Phase 3, Randomized Trial of Autologous Dendritic Cell Immunotherapy (AGS-003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (ADAPT)
Principal Investigator(s): Michael A. Palese

A Pilot Study of Abiraterone Acetate in African American/Black Patients with Castration Resistant Prostate Cancer
Principal Investigator(s): Matthew Galsky